Smoking and overweight: negative prognostic factors in stage III epithelial ovarian cancer

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Anette Kjaerbye-ThygesenSusanne Krüger Kjaer

Abstract

Smoking and overweight are associated with poorer prognosis in several cancer types. The prognostic effect of smoking and body mass index (BMI) on ovarian cancer is unknown. Ovarian cancer cases were from the Danish MALOVA (MALignant OVArian cancer) study. Information on smoking status and BMI was obtained from a personal interview conducted closely after primary surgery. Cox regression models were used to estimate adjusted hazard ratios (HR) and 95% confidence intervals (95% CI) for ovarian cancer-specific death in relation to smoking variables and BMI. A total of 295 women with stage III epithelial ovarian cancer were identified and followed to death or for a median of 7.3 years (range, 5.4-9.5 years). Median survival time for normal-weight never smokers was 2.8 years (95% CI, 2.3-3.2) compared with 1.2 years (95% CI, 0.8-2.3) for overweight current smokers. Current smokers had a significantly increased risk of ovarian cancer death compared with never smokers in multivariate Cox analysis (HR, 1.65; 95% CI, 1.22-2.24). The negative effect of smoking diminished with increasing time since a former smoker had stopped smoking (HR, 0.89; 95% CI, 0.80-0.98 per 5 years since stop of smoking). Overweight women also had an increased ri...Continue Reading

References

Aug 1, 1997·International Journal of Epidemiology·G Boström, F Diderichsen
Mar 24, 1998·Annual Review of Medicine·L Flancbaum, P S Choban
Sep 10, 1998·The Journal of Nutrition·J DallongevilleP Amouyel
Jun 9, 1999·International Journal of Cancer. Journal International Du Cancer·H I HallC A Swanson
Jul 7, 2000·Seminars in Surgical Oncology·C H Holschneider, J S Berek
Sep 21, 2000·Journal of the National Cancer Institute·H Yu, T Rohan
Apr 25, 2003·The New England Journal of Medicine·Eugenia E CalleMichael J Thun
May 10, 2003·Obstetrics and Gynecology·Solveig TingulstadBjørn Hagen
May 14, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anne McTiernanRachel Ballard-Barbash
Jul 30, 2003·Lancet·Martin VesseyDavid Yeates
Mar 17, 2004·The Breast : Official Journal of the European Society of Mastology·A R Carmichael, T Bates
Jul 21, 2004·Gynecologic Oncology·Séverine CunatPascal Pujol
Aug 24, 2004·Oncogene·Eugenia E Calle, Michael J Thun
Oct 27, 2004·International Journal of Cancer. Journal International Du Cancer·Freddie BrayCarlo La Vecchia
Nov 10, 2004·Archives of Internal Medicine·Eva GludJan Blaakaer
Jan 11, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·J O EbbertP Yang
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Mar 15, 2005·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Katrina F TriversWong-Ho Chow
May 17, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Min ZhangC D'Arcy J Holman
Sep 20, 2005·Acta Obstetricia Et Gynecologica Scandinavica·Anette Kjaerbye-ThygesenSusanne Krüger Kjaer

❮ Previous
Next ❯

Citations

Dec 18, 2007·Cancer Causes & Control : CCC·Mary Anne RossingNoel S Weiss
Apr 9, 2008·Cancer Causes & Control : CCC·Karsten MünstedtFolker E Franke
Oct 20, 2009·Nutrition and Cancer·Elisa V BanderaLorna Rodriguez-Rodriguez
Mar 23, 2011·Human Molecular Genetics·Celeste Leigh PearceAnna H Wu
Nov 15, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hyun-Sik YangSang Min Park
Jun 26, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·I Skírnisdóttir, B Sorbe
May 10, 2008·Archives of Physiology and Biochemistry·Andrew G RenehanCaroline Dive
Feb 7, 2016·Cancer Epidemiology·Camilla PræstegaardUNKNOWN Ovarian Cancer Association Consortium
Jan 16, 2016·Current Oncology Reports·Sarah A PurcellCarla M Prado
May 24, 2008·International Journal of Cancer. Journal International Du Cancer·Ling YangElisabete Weiderpass
May 3, 2008·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Estrid V S HøgdallSusanne K Kjaer
Jul 30, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Estrid V S HøgdallClaus K Høgdall
Sep 11, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Mel C HeeranEstrid V S Hogdall
Nov 30, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Lene SeibaekNiels Christian Hvidt
Nov 22, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Emma J CrosbieAndrew G Renehan
May 18, 2016·Gynecologic Oncology·Elizabeth M PooleKathryn L Terry
Oct 1, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Freddy SitasDianne O'Connell
Jan 8, 2017·International Journal of Cancer. Journal International Du Cancer·Camilla PraestegaardUNKNOWN Ovarian Cancer Association Consortium
Nov 7, 2019·International Journal of Cancer. Journal International Du Cancer·Tianyi WangShelley S Tworoger
Jun 8, 2017·British Journal of Cancer·Elisa V BanderaLawrence H Kushi
May 23, 2012·Cancer Prevention Research·Melinda M ProtaniPenelope M Webb
May 3, 2019·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Aili ZhouKirsten B Moysich
Dec 14, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Christina M NaglePenelope M Webb
Mar 21, 2007·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kirsten B MoysichJeannine A Villella
Feb 4, 2010·Acta Obstetricia Et Gynecologica Scandinavica·Farah Diba BegumClaus Høgdall

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved